Condition

Breast Cancer

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 8,916 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials8,916

Recruiting1,148

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Researching the Effect of Exercise on CancerNCT04589468 · 2026-10-30

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain MetastasesNCT07619534 · 2026-10-12

INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE StudyNCT07671937 · 2026-10-02

Hypofractionated vs. Conventionally Fractionated Postmastectomy Radiotherapy After Implant-Based ReconstructionNCT07835139 · 2026-10-01

An Investigation Into Dielectric Testing for the Evaluation and Characterisation of Breast Tissue Using a Novel Time-Domain Bioimpedance ToolNCT07782814 · 2026-09-30

Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral NeuropathyNCT07410169 · 2026-09-29

Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer TreatmentNCT07553234 · 2026-09-21

CBD for Breast Cancer Primary TumorsNCT06148038 · 2026-09-18

Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for CancerNCT07429487 · 2026-09-15

Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast CancerNCT07614620 · 2026-09-15

A Study of a Side Effects and Resource Navigation Program for People With CancerNCT07646847 · 2026-09-14

Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Systemic TherapyNCT07829848 · 2026-09-12

Precision Supplemental Imaging in Women With Dense BreastsNCT07277738 · 2026-09-09

The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer ImmunotherapyNCT07039474 · 2026-09-08

Utility of a Mobile Application for Young Women With Breast CancerNCT07009093 · 2026-09-01

HER2 Vaccine for Locally Advanced Breast CancerNCT06949410 · 2026-09-01

Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast CancerNCT07109817 · 2026-09-01

Radiation Therapy and Thymus Function in Young Women With Breast CancerNCT07725172 · 2026-09-01

Role of Tumor Microbiota in the Response to Neoadjuvant Therapy in Patients Affected by Triple Negative Breast CancerNCT07808086 · 2026-09-01

A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast CancerNCT07678957 · 2026-08-31

Evaluation of the Impact of Pre-habilitation Using Physiotherapy and Mechanical Stimulation on Shoulder Pain and Mobility in Patients Undergoing Breast Reconstruction Using a Latissimus Dorsi FlapNCT07418060 · 2026-08-28

A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast CancerNCT07766018 · 2026-08-18

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsNCT07753226 · 2026-08-18

A Study of Romosozumab in People With Breast Cancer and OsteoporosisNCT07776613 · 2026-08-17

SL-28 for Advanced Solid TumoursNCT07341737 · 2026-08-14

Pharmacologic Therapies to Mitigate Radiation- Associated Heart DiseaseNCT07685938 · 2026-08-12

A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast CancerNCT07768436 · 2026-08-11

Diagnostic Prediction Model for De Novo Metastatic Breast CancerNCT07752238 · 2026-08-10

Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)NCT07502352 · 2026-08-10

Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB OmissionNCT07803081 · 2026-08-06

A Real-world Study Observing Treatment Patterns and Clinical Results for Patients in China With Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer.NCT07743944 · 2026-08-05

Precision Navigation to Improve Community Cancer Screening ParticipationNCT07676383 · 2026-08-04

Supporting Health Including Endocrine Treatment for Long DurationNCT07482384 · 2026-08-04

Exercise Oncology Clinic Pilot Feasibility TrialNCT07765927 · 2026-08-03

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerNCT06251544 · 2026-08-03

Planning Grant for TOPS for Breast Cancer SurvivorsNCT06658912 · 2026-08-03

Culmerciclib in HR+/HER2+ Advanced Breast CancerNCT07732491 · 2026-08-01

Weight Management After Cancer for Survivors in Rural CommunitiesNCT07426952 · 2026-08-01

Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMDNCT07694986 · 2026-08-01

Evaluation and Outcomes of SAVI Scout MD for Localized Breast SurgeryNCT07686250 · 2026-07-29

Tai Chi for Reducing Aromatase Inhibitor-Induced ArthralgiaNCT07737951 · 2026-07-27

EXERT-BC Cardio: Cardio or Conditioning Training With Breast CancerNCT07739563 · 2026-07-27

68Ga-SorB PET/CT Imaging in Patients With Solid TumorsNCT07760012 · 2026-07-24

Clinical Study to Assess the Safety and Performance of Kenko Breast AI+ Medical Device as an Aid to Breast Cancer Diagnosis in Adult WomenNCT07580105 · 2026-07-22

Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast CancerNCT07844941 · 2026-07-22

Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN)NCT07779135 · 2026-07-15

Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast CancerNCT07593976 · 2026-07-15

Generative AI Patient Education Module for Breast OncologyNCT07512271 · 2026-07-14

EFFECTS OF SPSIP BLOCK ON PERIOPERATİVE INFLAMMATION AND TLR4 IN BREAST CANCER SURGERYNCT07843212 · 2026-07-14

BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine TherapyNCT07597993 · 2026-07-12

Biopsy-site-marker in Breast CancerNCT07833566 · 2026-07-09

Stress Reduction Through AcupunctureNCT07132034 · 2026-07-07

A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast CancerNCT07698314 · 2026-07-06

Instagram and Podcast Intervention for Breast Cancer Awareness and ScreeningNCT07673588 · 2026-07-06

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+/HER2- Breast Cancer After Failure of Prior Endocrine Therapy(PANKU-Breast03)NCT07648914 · 2026-07-06

Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer PatientsNCT07641985 · 2026-07-01

A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid TumorsNCT07661641 · 2026-07-01

Pilot SMART of a Remotely Delivered, Physical Activity Intervention for Breast Cancer SurvivorsNCT07706556 · 2026-06-30

Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)NCT07528638 · 2026-06-29

Analgesic Efficacy of Combined PECS II and PIP Block Versus Thoracic Paravertebral Block Post-MastectomyNCT07738770 · 2026-06-29

Common interventions

Leading sponsors

Memorial Sloan Kettering Cancer Center211 Fudan University153 M.D. Anderson Cancer Center142 Hoffmann-La Roche135 Dana-Farber Cancer Institute118 AstraZeneca114 National Cancer Institute (NCI)109Mayo Clinic76 Alliance for Clinical Trials in Oncology73 Novartis Pharmaceuticals72 UNC Lineberger Comprehensive Cancer Center67 Stanford University57 Case Comprehensive Cancer Center56 Massachusetts General Hospital51 Pfizer51

Trial status mix

COMPLETED4,425

UNKNOWN1,368

RECRUITING1,148

TERMINATED705

ACTIVE_NOT_RECRUITING534

NOT_YET_RECRUITING373

WITHDRAWN288

ENROLLING_BY_INVITATION41

SUSPENDED26

AVAILABLE3

APPROVED_FOR_MARKETING2

NO_LONGER_AVAILABLE2

TEMPORARILY_NOT_AVAILABLE1

Phase mix

NA2,828

PHASE22,180

PHASE11,042

PHASE3855

PHASE4175

EARLY_PHASE1128

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.